Over the past several years, there has been an alarming rise in the prevalence of non-healing chronic wounds, with estimates indicating that over two percent of the population in developed countries may be affected. Next to malnutrition, obesity, diabetes and smoking, the age of the patient poses a notable risk factor, as the prevalence is increased in those over 65 years of age. The impact of impaired wound healing on the healthcare system is significant, reducing patient’s quality of life and imposing a high socioeconomic burden with mortality rates comparable to those observed in cancer patients. As chronic wounds are characterized by an environment that facilitates the invasion and proliferation of pathogens, the presence of bacterial biofilms is a unifying characteristic, irrespective of the aetiology of the non-healing wounds. A meta-analysis of clinical studies conducted by Malone et al. revealed that biofilms are present in 78% of chronic wounds. Due to their pronounced virulence and their resistance to the immune system as well as conventional antimicrobial agents, they contribute greatly to prolonged healing periods of the wounds. As the population ages and becomes more susceptible to multiple health conditions, there is growing emphasis on the development of effective treatments for chronic wounds and related infections, from both a healthcare and a humanitarian point of view. In order to investigate the processes involved in physiological wound healing and the pathogenesis of chronic and biofilm-infected wounds, as well as to develop new effective treatment strategies, it is vital to employ a combination of model systems with high predictive power and comprehensive analytical techniques. Within this thesis, the applicability of different ex vivo and in vitro human skin wound models was assessed in the context of the evaluation of novel drug delivery strategies and the implementation of an infected wound model. Furthermore, innovative analytical techniques were utilized to either enhance established methodologies or compensate for their shortcomings. To date, the majority of methods employed for the analysis of wound tissue during healing are limited by their destructive nature, their restriction to small regions of interest while neglecting the surface structure of wounds, or their lack of molecular information. To overcome these limitations, the first objective of this thesis was the development of a non-invasive dual-technique approach that couples optical profilometry with label-free confocal Raman microscopy for a comprehensive investigation of structured wound surfaces during healing. To this end, wound models based on excised human skin tissue were prepared and subjected to optical profilometry and histological analysis. The micrographs obtained from optical profilometry enabled the differentiation of the cornified epidermis, the re-epithelialized regions, and the dermis, and were employed to determine the extent of re-epithelialization. A statistical evaluation of the results from optical profilometry and histologic analysis led to the conclusion that profilometry analysis is not only equally suitable, but a superior alternative to histologic examination for the evaluation of wound healing. The acquired topographic wound images also permitted the simultaneous surface contour guided tracking of molecular changes using confocal Raman microscopy. The Raman signals enabled the differentiation between the dermis and epidermis, as well as between the epidermis and re-epithelialized areas. Moreover, time-dependent changes during wound healing could be assessed in the re-epithelialized area. The Raman signals clearly reflected the progression of the re-epithelialized area from a single basal cell layer to a stratification of new viable epidermis. The results of this study successfully demonstrated the applicability of this dual-technique approach. This methodology enabled the topographical imaging and quantification of re-epithelialization of ex vivo wounds in a single pass, while also acquiring molecular information on three-dimensionally structured wound surfaces with high spatial resolution. In light of the ethical considerations associated with the assessment of novel therapeutics in humans, the use of advanced human in vitro and ex vivo models is essential for the generation of predictive preclinical human evidence of wound healing potential for innovative therapeutics. Thus, the second objective of this thesis was the implementation of an ex vivo human skin wound model simulating chronic non-healing conditions to assess the impact of therapeutic interventions on the wound proteome in the context of early formulation development.